ABSTRACT
BACKGROUND: Whether infection with SARS-CoV-2 leads to excess risk of requiring hospitalization or intensive care in persons with diabetes has not been reported, nor have risk factors in diabetes associated with increased risk for these outcomes. METHODS: We included 44,639 and 411,976 adult patients with type 1 and type 2 diabetes alive on Jan 1, 2020, and compared them to controls matched for age, sex, and county of residence (n=204,919 and 1,948,900). Age- and sex-standardized rates for COVID-19 related hospitalizations, admissions to intensive care and death, were estimated and hazard ratios were calculated using Cox regression analyses. FINDINGS: There were 10,486 hospitalizations and 1,416 admissions into intensive care. A total of 1,175 patients with diabetes and 1,820 matched controls died from COVID-19, of these 53â¢2% had been hospitalized and 10â¢7% had been in intensive care. Patients with type 2 diabetes, compared to controls, displayed an age- and sex-adjusted hazard ratio (HR) of 2â¢22, 95%CI 2â¢13-2â¢32) of being hospitalized for COVID-19, which decreased to HR 1â¢40, 95%CI 1â¢34-1â¢47) after further adjustment for sociodemographic factors, pharmacological treatment and comorbidities, had higher risk for admission to ICU due to COVID-19 (age- and sex-adjusted HR 2â¢49, 95%CI 2â¢22-2â¢79, decreasing to 1â¢42, 95%CI 1â¢25-1â¢62 after adjustment, and increased risk for death due to COVID-19 (age- and sex-adjusted HR 2â¢19, 95%CI 2â¢03-2â¢36, complete adjustment 1â¢50, 95%CI 1â¢39-1â¢63). Age- and sex-adjusted HR for COVID-19 hospitalization for type 1 diabetes was 2â¢10, 95%CI 1â¢72-2â¢57), decreasing to 1â¢25, 95%CI 0â¢3097-1â¢62) after adjustment⢠Patients with diabetes type 1 were twice as likely to require intensive care for COVID-19, however, not after adjustment (HR 1â¢49, 95%CI 0â¢75-2â¢92), and more likely to die (HR 2â¢90, 95% CI 1â¢6554-5â¢47) from COVID-19, but not independently of other factors (HR 1â¢38, 95% CI 0â¢64-2â¢99). Among patients with diabetes, elevated glycated hemoglobin levels were associated with higher risk for most outcomes. INTERPRETATION: In this nationwide study, type 2 diabetes was independently associated with increased risk of hospitalization, admission to intensive care and death for COVID-19. There were few admissions into intensive care and deaths in type 1 diabetes, and although hazards were significantly raised for all three outcomes, there was no independent risk persisting after adjustment for confounding factors.
ABSTRACT
AIM: To study the characteristics and outcome among cardiac arrest cases with COVID-19 and differences between the pre-pandemic and the pandemic period in out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest (IHCA). METHOD AND RESULTS: We included all patients reported to the Swedish Registry for Cardiopulmonary Resuscitation from 1 January to 20 July 2020. We defined 16 March 2020 as the start of the pandemic. We assessed overall and 30-day mortality using Cox regression and logistic regression, respectively. We studied 1946 cases of OHCA and 1080 cases of IHCA during the entire period. During the pandemic, 88 (10.0%) of OHCAs and 72 (16.1%) of IHCAs had ongoing COVID-19. With regards to OHCA during the pandemic, the odds ratio for 30-day mortality in COVID-19-positive cases, compared with COVID-19-negative cases, was 3.40 [95% confidence interval (CI) 1.31-11.64]; the corresponding hazard ratio was 1.45 (95% CI 1.13-1.85). Adjusted 30-day survival was 4.7% for patients with COVID-19, 9.8% for patients without COVID-19, and 7.6% in the pre-pandemic period. With regards to IHCA during the pandemic, the odds ratio for COVID-19-positive cases, compared with COVID-19-negative cases, was 2.27 (95% CI 1.27-4.24); the corresponding hazard ratio was 1.48 (95% CI 1.09-2.01). Adjusted 30-day survival was 23.1% in COVID-19-positive cases, 39.5% in patients without COVID-19, and 36.4% in the pre-pandemic period. CONCLUSION: During the pandemic phase, COVID-19 was involved in at least 10% of all OHCAs and 16% of IHCAs, and, among COVID-19 cases, 30-day mortality was increased 3.4-fold in OHCA and 2.3-fold in IHCA.